Long-Term Liabilities: The sum of all non-current liabilities.
Regentis Biomaterials Ltd. (RGNT) had Long-Term Liabilities of $35.10M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.47M |
|
-- |
|
-- |
|
$0.47M |
|
$9.71M |
|
-- |
|
|
Long-Term Liabilities |
$35.10M |
$44.81M |
|
$-44.33M |
|
$-44.33M |
|
$-44.33M |
|
0.16M |
|
| Cash Flow Statement Financials | |
$-0.34M |
|
-- |
|
$0.30M |
|
$0.23M |
|
$0.19M |
|
$-0.04M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|